Literature DB >> 23331820

Short-term intravenous fish oil and pediatric intestinal failure associated liver disease: 3-year follow-up on liver function and nutrition.

Kara Calkins1, Allison Lowe, Stephen B Shew, James C Y Dunn, Laurie Reyen, Douglas G Farmer, Sherin U Devaskar, Robert Venick.   

Abstract

Intravenous fish oil (FO) has changed the management of intestinal failure associated liver disease (IFALD). This report describes two IFALD patients who received FO for 5 and 10 months, respectively and reports on their 3-year follow-up.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23331820      PMCID： PMC3553503          DOI： 10.1016/j.jpedsurg.2012.10.044

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN： 0022-3468            Impact factor:   2.545


  18 in total

1.  Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.

Authors:  Gertrud Angsten; Yigael Finkel; Steven Lucas; Ann-Marie Kassa; Mattias Paulsson; Helene Engstrand Lilja
Journal:  JPEN J Parenter Enteral Nutr       Date:  2012-01-24       Impact factor: 4.016

2.  Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.

Authors:  Kathleen M Gura; Christopher P Duggan; Sharon B Collier; Russell W Jennings; Judah Folkman; Bruce R Bistrian; Mark Puder
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

3.  Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children.

Authors:  V Colomb; A Jobert-Giraud; F Lacaille; O Goulet; J C Fournet; C Ricour
Journal:  JPEN J Parenter Enteral Nutr       Date:  2000 Nov-Dec       Impact factor: 4.016

4.  Intravenous fish oil emulsion attenuates total parenteral nutrition-induced cholestasis in newborn piglets.

Authors:  J E Van Aerde; D R Duerksen; L Gramlich; J B Meddings; G Chan; A B Thomson; M T Clandinin
Journal:  Pediatr Res       Date:  1999-02       Impact factor: 3.756

5.  Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome.

Authors:  Ivan R Diamond; Anca Sterescu; Paul B Pencharz; Jae H Kim; Paul W Wales
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-02       Impact factor: 2.839

6.  Parenteral nutrition-associated cholestasis in small for gestational age infants.

Authors:  Daniel T Robinson; Richard A Ehrenkranz
Journal:  J Pediatr       Date:  2007-10-26       Impact factor: 4.406

7.  Very low birth weight preterm infants with surgical short bowel syndrome: incidence, morbidity and mortality, and growth outcomes at 18 to 22 months.

Authors:  Conrad R Cole; Nellie I Hansen; Rosemary D Higgins; Thomas R Ziegler; Barbara J Stoll
Journal:  Pediatrics       Date:  2008-09       Impact factor: 7.124

8.  Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.

Authors:  Kathleen M Gura; Sang Lee; Clarissa Valim; Jing Zhou; Sendia Kim; Biren P Modi; Danielle A Arsenault; Robbert A M Strijbosch; Suzanne Lopes; Christopher Duggan; Mark Puder
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124

9.  Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR.

Authors:  Beth A Carter; Olga A Taylor; Daniel R Prendergast; Tracy L Zimmerman; Richard Von Furstenberg; David D Moore; Saul J Karpen
Journal:  Pediatr Res       Date:  2007-09       Impact factor: 3.756

10.  Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids).

Authors:  George Ekema; Diego Falchetti; Giovanni Boroni; Anna Rita Tanca; Cristian Altana; Laura Righetti; Michela Ridella; Marco Gambarotti; Luisa Berchich
Journal:  J Pediatr Surg       Date:  2008-06       Impact factor: 2.545
View more
  3 in total

1.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

2.  Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil.

Authors:  Caroline Wang; Robert S Venick; Stephen B Shew; James C Y Dunn; Laurie Reyen; Rong Gou; Kara L Calkins
Journal:  JPEN J Parenter Enteral Nutr       Date:  2018-11-08       Impact factor: 4.016

3.  Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil.

Authors:  Kara L Calkins; James C Y Dunn; Stephen B Shew; Laurie Reyen; Douglas G Farmer; Sherin U Devaskar; Robert S Venick
Journal:  JPEN J Parenter Enteral Nutr       Date:  2013-07-26       Impact factor: 4.016
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.